Norvik Pharmaceuticals Private Limited
About Norvik Pharmaceuticals Private Limited
Data last updated:
Norvik Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 January 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2004PTC033198. Its GSTIN is 29AABCN8857G1ZZ (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suma Kishore and Prema Kumari Munegowda.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at No.2115 Norvikvillad – Block Sahakarnagar, Bangalore, Karnataka, India – 560092.
As per the financials filed for FY 2020, the company reported a revenue of ₹36.03 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net loss of ₹3.03 Lakh (net margin -8.4%) and EBITDA of -₹2.77 Lakh (EBITDA margin -7.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 69% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.2115 Norvikvillad – Block Sahakarnagar, Bangalore, Karnataka, India – 560092
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Norvik Pharmaceuticals Private Limited
The main business activity of Norvik Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Norvik Pharmaceuticals Private Limited FY 2020 filings available
Norvik Pharmaceuticals Private Limited reported revenue of ₹36.03 Lakh (up 15% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Norvik Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 69% over five years, including 15% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Norvik Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹36.03 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.77 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.03 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Norvik Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -8.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Norvik Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Norvik Pharmaceuticals Private Limited
Norvik Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| I.J. Pharmaceuticals Private Limited | ₹36.11 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Delhi, India |
| BRS Mercantiles Private Limited | ₹36.11 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | Gurgaon, Haryana, India |
| Dipjyoti Pharmaceuticals Private Limited | ₹36.11 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Kolkata, West Bengal, India |
| Eshan Pharmaceuticals Pvt Ltd | ₹36.05 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Ahmedabad, Gujarat, India |
| Boneym Pharmaceuticals Private Limited | ₹36.03 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Delhi, India |
| Norvik Pharmaceuticals Private Limited this company | ₹36.03 Lakh (FY 2020) | •••• | •••• | 15.0% | •••• | Bangalore, Karnataka, India |
| Somsa Pharmaceuticals Private Limited | ₹36.01 Lakh (FY 2020) | •••• | •••• | 339.0% | •••• | Sri Ganga Nagar, Rajasthan, India |
| Lepranal Pharmaceuticals Private Limited | ₹36 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Samesia Biotech Private Limited | ₹35.97 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Lucknow, Uttar Pradesh, India |
| Xyiris Pharmaceuticals Private Limited | ₹35.95 Lakh (FY 2025) | •••• | •••• | 20.0% | •••• | Bhubaneswar, Odisha, India |
| Acecure Pharmaceuticals Private Limited | ₹35.94 Lakh (FY 2024) | •••• | •••• | 245.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Norvik Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Norvik Pharmaceuticals Private Limited
Norvik Pharmaceuticals Private Limited is audited by N MADHAVA & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N MADHAVA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Norvik Pharmaceuticals Private Limited
Norvik Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suma Kishore | Director | 16 Jan 2004 | 22 Years 8 Months | Current |
| Prema Kumari Munegowda | Director | 16 Jan 2004 | 22 Years 8 Months | Current |
Ownership and Shareholding of Norvik Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Norvik Pharmaceuticals Private Limited
Norvik Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Norvik Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Norvik Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Norvik Pharmaceuticals Private Limited
Norvik Pharmaceuticals Private Limited has 2 board changes on record since 2004: 2 appointments. The latest: Prema Kumari Munegowda was appointed as Director on 16 Jan 2004.
Credit Ratings, Litigation & Regulatory Alerts for Norvik Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Norvik Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Norvik Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Norvik Pharmaceuticals Private Limited
Norvik Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCN8857G1ZZ | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Norvik Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Norvik Pharmaceuticals Private Limited
Norvik Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 January 2004 (22+ years old) and is registered under CIN U24231KA2004PTC033198.
Norvik Pharmaceuticals reported revenue of ₹36.03 Lakh for FY 2020 (up 15% YoY).
Norvik Pharmaceuticals has 2 current directors:
- Suma Kishore - Director
- Prema Kumari Munegowda - Director
Norvik Pharmaceuticals reported a net loss of ₹3.03 Lakh (net margin -8.4%) and EBITDA of -₹2.77 Lakh (EBITDA margin -7.7%) for FY 2020, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Norvik Pharmaceuticals is 8% over three years and 69% over five years. In the latest year (FY 2020) revenue rose 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Norvik Pharmaceuticals is 29AABCN8857G1ZZ, registered in Karnataka.
The CIN (Corporate Identification Number) of Norvik Pharmaceuticals is U24231KA2004PTC033198. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Norvik Pharmaceuticals was incorporated on 16 January 2004, making it 22+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Norvik Pharmaceuticals by revenue are I.J. Pharmaceuticals Private Limited, BRS Mercantiles Private Limited, Dipjyoti Pharmaceuticals Private Limited, Eshan Pharmaceuticals Pvt Ltd, Boneym Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Prema Kumari Munegowda was appointed as Director on 16 Jan 2004. Suma Kishore was appointed as Director on 16 Jan 2004.
The registered office of Norvik Pharmaceuticals is at No.2115 Norvikvillad – Block Sahakarnagar, Bangalore, Karnataka, India – 560092.